Skip to main content
Premium Trial:

Request an Annual Quote

Good News, HapMap: We Still Need You

Dan Koboldt has a blog post at MassGenomics about how HapMap data is still useful, despite concerns that it would be made obsolete by the 1,000 Genomes Project. Koboldt reports on a talk he attended by the University of Chicago's Wei Zhang, whose group is "still leveraging the HapMap resource in numerous ways to better understand the relationship between genotype and phenotype." Koboldt sums up a number of efforts described by Zhang, including correlating gene expression and genotype, studying isoform variation, measuring tox profiles of anti-cancer drugs, and more. He adds that "efforts are currently under way at the University of Chicago to measure two more cell phenotypes on the HapMap samples" -- microRNA expression and DNA methylation.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.